Mankind Pharma Acquires Rivotril Brand, Bolsters CNS Therapy Focus
New Delhi, March 18, 2026: Mankind Pharma Limited announced today the acquisition of the Rivotril brand from Roche for the Indian market. The agreement grants Mankind Pharma exclusive rights to manufacture, market, and distribute the product throughout the country.Rivotril is the innovator brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions. The acquisition reinforces Mankind Pharma's focus on chronic and central nervous system (CNS) therapies, complementing its existing neuro portfolio.Atish Majumdar, Senior President, Sales & Marketing, Mankind Pharma Specialty Business, stated that the acquisition aligns with...